Back to search

Article

Upregulated CDKN2A expression may be an independent protective factor in Luminal-like breast cancer

2020-05-29

Abstract excerpt

<title>Abstract</title> <p>Background Previous studies revealed that CDKN2A (cyclin-dependent kinase inhibitor 2A) functioned as a tumour suppressor in various types of malignant tumours. The aim of the study was to clarify the value of CDKN2A expression in the prognosis of breast cancer. Method Using the Cancer Genome Atlas (TCGA) database, we compared CDKN2A mRNA levels between breast cancer tissues and normal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
abedcf0c-f8bd-55a2-abef-b15a14bd2681
DOI
10.21203/rs.3.rs-29971/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Upregulated CDKN2A expression may be an independent protective factor in Luminal-like breast cancerDOI 10.21203/rs.3.rs-29971/v1
Upregulated CDKN2A expression may be an independent protective factor in Luminal-like breast cancerSemantic proximity
Bioinformatics analysis reveling prognostic roles of CDK1 in breast cancerSemantic proximity
Differential Expression and Prognostic Significance of CDK1 and CDK6 in Breast Cancer: A Multi-Omics ApproachSemantic proximity
ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironmentSemantic proximity
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtypeSemantic proximity
Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancerSemantic proximity
Key Genes and Prognostic Analysis in HER2+ Breast CancerSemantic proximity
NUSAP1 and KIAA0101 downregulation by neo-adjuvant therapy is associated with better outcome and survival in breast cancer.Semantic proximity
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeSemantic proximity
Identification and validation of RAB2A as a new prognostic biomarker for breast cancerSemantic proximity
HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and OutcomeSemantic proximity
Select a neighboring publication to make it the new centre.